Bluebird Care has been acquired by Interim Healthcare Inc.
US-based care-at-home franchisor Interim Healthcare Inc. has acquired Bluebird Care, based in the UK, a national provider of care in the home. Financial details have not been provided.
Bluebird Care offers a unique service of tailored care visits from 30 minutes to full live-in support. The company has nearly 200 offices in the UK and the Republic of Ireland.
Founded in 1966, Interim Healthcare has more than 300 independently owned and operated franchise locations providing a variety of home health, senior care, hospice, palliative care, pediatric care and healthcare staffing services.
UK-based Oaklins Smith & Williamson, assisted by the team in Los Angeles, advised the seller in this transaction.
Talk to the deal team
Brian Livingston
Oaklins Evelyn Partners
Gary S. Rabishaw
Oaklins Intrepid
Related deals
Bayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn moreSaideep Healthcare and Research has raised equity
Saideep Healthcare and Research Private Limited has successfully completed a fundraising. This funding will help Saideep become a leading healthcare brand, offering advanced specialties across the region. The funds from this collaboration will be used to diversify into new and complex specialties, expand infrastructure and meet the growing demand for high-quality healthcare services in Western India.
Learn moreVivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
Learn more